Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$222,440
-$3,820,328 QoQ
Shares Held
910
-95.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $740,904,213 across 7 Drug Manufacturers - General names. JNJ ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
331,823 | $305,200,840 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,392,094 | $205,730,501 | |
| 3 | ABBV |
AbbVie Inc.
|
536,277 | $116,634,884 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
429,035 | $59,794,607 | |
| 5 | AMGN |
Amgen Inc
|
95,027 | $33,435,249 | |
| 6 | AZN |
Astrazeneca PLC
|
100,830 | $19,885,692 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
910 | $222,440 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $222,440 | 910 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,042,768 | 19,535 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $139,174,583 | 750,591 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $115,161,738 | 753,923 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $139,031,632 | 838,348 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $42,901,233 | 296,648 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $105,390,275 | 721,061 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $92,445,128 | 584,393 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $68,298,984 | 435,747 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $58,250,500 | 374,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $74,250,285 | 448,588 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $46,802,095 | 301,949 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $51,996,927 | 294,350 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $64,719,311 | 396,176 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $32,530,482 | 183,260 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,459,869 | 64,661 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,801,927 | 80,680 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,374,806 | 225,231 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $52,931,950 | 321,306 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $36,066,607 | 219,450 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $34,537,041 | 219,450 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $32,671,716 | 219,450 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $40,265,744 | 286,324 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $42,490,971 | 324,037 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||